Literature DB >> 17506849

Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions.

B Prato1, A Ghelardi, A Gadducci, I Marchetti, C Di Cristofano, G Di Coscio, G Bevilacqua, A R Genazzani.   

Abstract

The aim of the present study was to assess recurrence rates and times in patients with squamous intraepithelial lesion (SIL) of the uterine cervix treated with loop electrosurgical excision procedure (LEEP) conization, in order to define categories of patients who have a different risk of recurrence and who need a different surveillance protocol. This study was carried out on 119 consecutive patients who underwent LEEP. All patients were followed up with cervical smear and colposcopy after 3, 6, and 12 months in the first-year posttreatment, and every 6-12 months afterwards. Human papillomavirus (HPV) testing was performed at the time of LEEP and repeated 3-6 months later. The histologic examination of LEEP specimens revealed stage IA1 squamous cell cervical cancer in 4 (3.4%) cases, high-grade SIL in 75 (63%) cases, and low-grade SIL in 40 (33.6%) cases. The four patients with stage IA1 cervical cancer were not included in the further analyses. Disease recurred in none of the 50 patients with negative posttreatment HPV testing, in 4 (9.3%) of the 43 patients with positive posttreatment HPV testing and negative surgical margins, and in 8 (36.4%) of 22 patients with positive posttreatment HPV testing and positive margins. The combined evaluation of surgical margin status and posttreatment HPV testing could allow to subdivide patients treated with LEEP into categories at different risk of recurrence, requiring new tailored surveillance procedures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17506849     DOI: 10.1111/j.1525-1438.2007.00965.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  14 in total

1.  The value of HPV-HR DNA testing during the follow-up after treatment of CIN3/AIS.

Authors:  Maja Banović; Vesna Mahovlić; Kristina Meljanac Salopek; Vladimir Banović; Ivan Babić; Slavko Orešković; Damir Babić
Journal:  Pathol Oncol Res       Date:  2014-11-29       Impact factor: 3.201

2.  Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infections.

Authors:  Philip E Castle; Aimée R Kreimer; Sholom Wacholder; Cosette M Wheeler; Laura A Koutsky; Greg Rydzak; Dennis W Buckman; Barry Graubard; Mark Schiffman
Journal:  J Infect Dis       Date:  2009-06-01       Impact factor: 5.226

3.  Clinical Implication of p16, Ki-67, and Proliferating Cell Nuclear Antigen Expression in Cervical Neoplasia: Improvement of Diagnostic Accuracy for High-grade Squamous Intraepithelial Lesion and Prediction of Resection Margin Involvement on Conization Specimen.

Authors:  Tae Hun Kim; Jee Hye Han; Eun Shin; Jae Hong Noh; Hee Seung Kim; Yong Sang Song
Journal:  J Cancer Prev       Date:  2015-03

4.  Positive Surgical Margin, HPV Persistence, and Expression of Both TPX2 and PD-L1 Are Associated with Persistence/Recurrence of Cervical Intraepithelial Neoplasia after Cervical Conization.

Authors:  Hui Zhang; Tingguo Zhang; Zongbing You; Youzhong Zhang
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

Review 5.  HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions.

Authors:  Luciano Mariani; Maria Teresa Sandri; Mario Preti; Massimo Origoni; Silvano Costa; Paolo Cristoforoni; Fabio Bottari; Mario Sideri
Journal:  J Cancer       Date:  2016-01-01       Impact factor: 4.207

6.  The Neutrophil-Lymphocyte Ratio Predicts Recurrence of Cervical Intraepithelial Neoplasia.

Authors:  Sungwook Chun; Kyusik Shin; Ki Hyung Kim; Heung Yeol Kim; Wankyu Eo; Ji Young Lee; Jeong Namkung; Sang Hoon Kwon; Suk Bong Koh; Hong-Bae Kim
Journal:  J Cancer       Date:  2017-07-15       Impact factor: 4.207

7.  Programmed death-1 (PD-1) expression in cervical intraepithelial neoplasia and its relationship with recurrence after conization.

Authors:  Hyeyoon Chang; Jin Hwa Hong; Jae Kwan Lee; Hyun Woong Cho; Yung Taek Ouh; Kyung Jin Min; Kyeong A So
Journal:  J Gynecol Oncol       Date:  2018-01-29       Impact factor: 4.401

8.  The risk factors of residual lesions and recurrence of the high-grade cervical intraepithelial lesions (HSIL) patients with positive-margin after conization.

Authors:  Jun-Yu Chen; Zhi-Ling Wang; Zhao-Yang Wang; Xing-Sheng Yang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

9.  Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution's Experience.

Authors:  Marco Petrillo; Margherita Dessole; Elettra Tinacci; Laura Saderi; Narcisa Muresu; Giampiero Capobianco; Antonio Cossu; Salvatore Dessole; Giovanni Sotgiu; Andrea Piana
Journal:  Vaccines (Basel)       Date:  2020-01-25

10.  Predictors of recurrence in patients with high-grade cervical intraepithelial neoplasia after cervical conization.

Authors:  Yan Ge; Yongli Liu; Yun Cheng; Yanbo Liu
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.